Margaret Braxton Managing Director, Payer Strategy and Regulatory Research CMS Strengthens Primary Care in 2024 Medicare Physician Fee Schedule while Specialists see Relative Cuts On November 2, CMS issued the

Margaret Braxton Managing Director, Payer Strategy and Regulatory Research November 2023 CMS Finalizes 2024 Physician Payment Rule On November 2, CMS issued the Medicare Physician Fee Schedule final rule for

Margaret Braxton Managing Director, Payer Strategy and Regulatory Research October 2023 Federal Court Limits Copay Accumulators On October 3, a federal judge ruled against a government policy that allowed copay

Margaret Braxton Managing Director, Payer Strategy and Regulatory Research September 2023 Congress and FDA Seek Drug Shortage Solutions Amid ongoing drug shortages for generic medications used to treat cancer, ADHD, and

Margaret Braxton Managing Director, Payer Strategy and Regulatory Research August 2023 FDA Approves First Oral Postpartum Depression Drug On August 4, the FDA granted approval to Zurzuvae, manufactured by Sage

Margaret Braxton Managing Director, Payer Strategy and Regulatory Research July 2023 CMS Releases Proposed Physician Payment Rule and OPPS Rule On July 13, CMS issued the Calendar Year 2024 Medicare

Behavioral Health Value-Based Care Outlook:   Transition to value-based payment models is popular in primary care settings and has been gaining traction amongst specialty groups. Integration and adoption of value-based

Margaret Braxton Managing Director, Payer Strategy and Regulatory Research June 2023 Debt Limit Deal Enacted with Minor Healthcare Changes The final legislative agreement passed by Congress to raise the debt